Literature DB >> 8491474

The search for the optimal immunohistochemical panel for the diagnosis of malignant mesothelioma.

L M Weiss, H Battifora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8491474     DOI： 10.1016/0046-8177(93)90079-v

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  5 in total

1.  Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.

Authors:  K M Amin; L A Litzky; W R Smythe; A M Mooney; J M Morris; D J Mews; H I Pass; C Kari; U Rodeck; F J Rauscher
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

2.  OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.

Authors:  C Edwards; J Oates
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

3.  Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.

Authors:  A S Abutaily; B J Addis; W R Roche
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

4.  Malignant mesothelioma of the pleura: interobserver variability.

Authors:  A Andrion; C Magnani; P G Betta; A Donna; F Mollo; M Scelsi; P Bernardi; M Botta; B Terracini
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

5.  Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung.

Authors:  A M Björkqvist; L Tammilehto; S Nordling; M Nurminen; S Anttila; K Mattson; S Knuutila
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.